An efficacy number that’s been widely and unquestioningly quoted by various media organizations — “85% effective” or “at least 85% effective” — is based entirely on a small study done in Africa in the 1980s that has major limitations and with “pretty weak” findings.

JAMA Network Open | Original Investigation

The findings supported the National Institute on Aging-Alzheimer’s Association (NIA-AA) research framework for Alzheimer’s disease, which is based on biomarkers of amyloid, tau, and neurodegeneration.

Since 1972, clinicians have used the Cookie Theft image to assist them diagnose speech and language problems as well as spatial and visual anomalies. However, a position presented in the Journal of the American Medical Association – Neurology suggests that frequent exposure to the Cookie Theft image may reduce patients’ self-confidence and undermine their sense of belonging and trust.

Results of a study published online ahead of print in Science Advances suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may hijack tunneling nanotubes to enter the brain and induce neurological symptoms.

The update, which was presented during a panel discussion at the Alzheimer Association International Conference 2022 (AAIC2022) in San Diego, CA, is based on evidence from real-world use of aducanumab and is intended to improve risk mitigation, safety monitoring, patient selection, and shared decision-making.